
Medmix Ltd
SIX:MEDX

Intrinsic Value
The intrinsic value of one
MEDX
stock under the Base Case scenario is
14.23
CHF.
Compared to the current market price of 10.96 CHF,
Medmix Ltd
is
Undervalued by 23%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Medmix Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Medmix Ltd
Balance Sheet Decomposition
Medmix Ltd
Current Assets | 261.2m |
Cash & Short-Term Investments | 118.1m |
Receivables | 65.7m |
Other Current Assets | 77.4m |
Non-Current Assets | 693m |
Long-Term Investments | 8m |
PP&E | 262m |
Intangibles | 388.8m |
Other Non-Current Assets | 34.2m |
Free Cash Flow Analysis
Medmix Ltd
CHF | |
Free Cash Flow | CHF |
Earnings Waterfall
Medmix Ltd
Revenue
|
483.9m
CHF
|
Cost of Revenue
|
-324.2m
CHF
|
Gross Profit
|
159.7m
CHF
|
Operating Expenses
|
-140.9m
CHF
|
Operating Income
|
18.8m
CHF
|
Other Expenses
|
-26.2m
CHF
|
Net Income
|
-7.4m
CHF
|
MEDX Profitability Score
Profitability Due Diligence
Medmix Ltd's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Score
Medmix Ltd's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
MEDX Solvency Score
Solvency Due Diligence
Medmix Ltd's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Score
Medmix Ltd's solvency score is 40/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MEDX Price Targets Summary
Medmix Ltd
According to Wall Street analysts, the average 1-year price target for
MEDX
is 22.95 CHF
with a low forecast of 20.2 CHF and a high forecast of 26.25 CHF.
Dividends
Current shareholder yield for MEDX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MEDX
stock under the Base Case scenario is
14.23
CHF.
Compared to the current market price of 10.96 CHF,
Medmix Ltd
is
Undervalued by 23%.